TipRanks
Go Ultimate55% OFF

MUROMACHI CHEMICALS INC. (4885) AI Stock Analysis

JP:4885

MUROMACHI CHEMICALS INC.

(TSE/TYO:4885)

Select Model
Rating:50Neutral
Price Target:JPY 893.00â–¼(-0.22% Downside)
Action:reiterated
Date:10/15/26

The company's financial health is mixed, with strong revenue growth and cash flow generation undermined by weak net margins and declining return on equity. Technical indicators show the stock in a downtrend, trading below key moving averages, which adds caution. Valuation is fair but not compelling. The overall score reflects a neutral outlook with balanced risks and limited near-term catalysts.

Positive Factors
Accelerating Revenue GrowthThe acceleration in revenue growth indicates improving demand and stronger commercial momentum across the company’s chemical products. If sustained, higher sales can support operating leverage, broaden customer adoption, and provide a stronger base for reinvestment over the next several quarters.
Negative Factors
Weakening Net ProfitabilityDeclining net margin shows that stronger operating performance is not fully reaching the bottom line. Persistent pressure from costs, non-operating items, or taxes could limit earnings conversion, weaken retained capital formation, and make future profitability less dependable despite revenue growth.

MUROMACHI CHEMICALS INC. (4885) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%JP:4885+23.89%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 3.30B
Dividend Yield
2.79%
Average Volume (3M)
9,525
Price to Earnings (P/E)
14.5
Beta (1Y)
0.88
Revenue Growth
14.73%
EPS Growth
7.50%
Country
Japan
Employees
203
Sector
General
Sector Strength
55
Industry
Medical - Pharmaceuticals

MUROMACHI CHEMICALS INC. Business Overview & Revenue Model

Company Description

Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; an...

How the Company Makes Money

MUROMACHI CHEMICALS INC. generates revenue primarily by selling its chemical products to business customers (B2B). Its earnings are driven by (1) product sales volume and (2) the unit pricing/mix of higher value-added functional materials versus more...

MUROMACHI CHEMICALS INC. Financial Statement Overview

Summary

Solid revenue growth and healthy cash flows are offset by weak net profitability and declining return on equity. The balance sheet is stable but shows moderate leverage.

Income Statement

45Neutral

Balance Sheet

55Neutral

Cash Flow

60Neutral
Financial statement breakdown
BreakdownMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue7.84B6.65B6.37B6.29B4.94B
Gross Profit2.30B1.91B1.82B1.72B1.63B
EBITDA933.95M540.83M623.24M493.14M493.49M
Net Income163.03M241.28M330.20M256.30M180.71M
Balance Sheet
Total Assets6.35B5.32B5.10B4.96B4.62B
Cash, Cash Equivalents and Short-Term Investments1.95B1.06B1.05B852.61M1.00B
Total Debt2.10B1.65B1.44B1.57B2.04B
Total Liabilities3.78B2.87B2.83B3.04B3.29B
Stockholders Equity2.58B2.45B2.27B1.92B1.33B
Cash Flow
Free Cash Flow578.13M-112.85M412.21M257.42M438.63M
Operating Cash Flow808.09M215.96M637.70M317.19M487.67M
Investing Cash Flow-237.79M-370.50M-232.23M-162.41M-57.73M
Financing Cash Flow317.78M123.20M-209.95M-172.39M-310.51M

MUROMACHI CHEMICALS INC. Technical Analysis

Technical Analysis SentimentNegative
Last Price895.00

Price Trends

50DMA900.12Negative
100DMA906.43Negative
200DMA964.11Negative

Market Momentum

MACD0.65Positive
RSI45.46Neutral
STOCH16.67Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4885, the sentiment is Negative. The current price of 895.00 is below the 20-day moving average (MA) of 909.25, below the 50-day MA of 900.12, and below the 200-day MA of 964.11, indicating a bearish trend. The MACD of 0.65 indicates Positive momentum. The RSI at 45.46 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4885.

MUROMACHI CHEMICALS INC. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4885 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6568JP:656873OutperformJPY 10.00B12.15―2.57%12.39%22.04%
JP:4093JP:409369NeutralJPY 14.44B11.14―3.39%-0.22%4.42%
JP:4040JP:404064NeutralJPY 10.11B2.90―1.50%0.56%238.99%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4885JP:488550NeutralJPY 3.30B14.54―2.79%14.73%7.50%
JP:4960JP:496044NeutralJPY 8.17B26.66―1.01%-5.34%113.57%

* General Sector Average

Performance Comparison

0%100%200%JP:4885JP:4040JP:4093JP:4960JP:6568Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:4885 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4885MUROMACHI CHEMICALS INC.895.00168.7123.23%
JP:4040NANKAI CHEMICAL COMPANY LIMITED4340.001695.0764.09%
JP:4093Toho Acetylene Co., Ltd.413.0068.0319.72%
JP:4960Chemipro Kasei Kaisya,Ltd.497.00136.7137.94%
JP:6568KNC Laboratories Co.,Ltd.1285.00187.3817.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 15, 2026